The global Glucose Management Systems market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Glucose Management Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glucose Management Systems market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Glucose Management Systems in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Glucose Management Systems manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
F. Hoffmann-La Roche (Switzerland)
Monarch Medical Technologies (US)
Animas Corporation (US)
LifeScan (US)
Johnson & Johnson (US)
DarioHealth Corp (Israel)
Abbott (US)
Senseonics (US)
Dexcom (US)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Data Management System
Insulin Delivery System
Combined System

Segment by Application
Hospitals
Clinics
Home Care Settings